Please wait a minute...
浙江大学学报(医学版)  2022, Vol. 51 Issue (1): 53-61    DOI: 10.3724/zdxbyxb-2021-0203
中药现代化     
清肺口服液在特发性肺纤维化中的治疗作用及网络药理学研究
张轶雯,盛孔胜,宋飞凤,潘宗富,邹小舟,刘宇佳,黄萍()
杭州医学院附属人民医院 浙江省人民医院临床药学中心药学部, 浙江 杭州 310014
Efficacy of Qingfei oral liquid for idiopathic pulmonary fibrosis in rats and related network pharmacology study
ZHANG Yiwen,SHENG Kongsheng,SONG Feifeng,PAN Zongfu,ZOU Xiaozhou,LIU Yujia,HUANG Ping()
Department of Pharmacy, Clinical Pharmacy Center, Zhejiang Provincial People’s Hospital, Affiliated People’s Hospital of Hangzhou Medical College, Hangzhou 310014, China
 全文: PDF(11308 KB)   HTML( 5 )
摘要:

目的:考察清肺口服液在特发性肺纤维化中的治疗作用及机制。方法:72只SD大鼠分为正常对照组、模型对照组、吡非尼酮组(给予吡非尼酮 50?mg·kg–1·次–1,每天2次)、清肺口服液组(给予清肺口服液3.6?mL/kg,每天1次)处理21?d,获取肺组织进行HE染色、马森染色和转化生长因子-β(TGF-β)免疫组织化学染色,其余组织进行匀浆后检测超氧化物歧化酶(SOD)、丙二醛(MDA)和谷胱苷肽(GSH)。采用网络药理学方法,利用BATMAN-TCM数据库检索清肺口服液组成药物的化学成分及其对应靶点,随后构建成分-靶点-疾病网络图,进行通路富集分析。结果:组织病理学结果提示,清肺口服液给药后可改善肺纤维化状态,且效果与吡非尼酮类似;清肺口服液可减少肺组织TGF-β表达,对SOD、MDA和GSH也有调控作用。成分-靶点-疾病网络构建及基因功能注释结果显示,清肺口服液与调控炎症、细胞外基质和细胞因子等通路相关。结论:清肺口服液可能通过调控炎症等信号通路发挥抗特发性肺纤维化作用。

关键词: 特发性肺纤维化清肺口服液网络药理学氧化还原转化生长因子-β大鼠    
Abstract:

Objective:To investigate the therapeutic effect and mechanism of Qingfei oral liquid in idiopathic pulmonary fibrosis. Methods: Seventy-two male SD rats were divided into control group, model group, pirofenidone group and Qingfei group with 18 animals in each group. The idiopathic pulmonary fibrosis was induced in last three groups by intratracheal injection of 3?mg/kg bleomycin; pirofenidone group was given oral administration of 50?mg/kg pirofenidone b.i.d for 21?d, and Qingfei group was given Qingfei oral liquid 3.6?mL/kg q.d for 21?d. Lung tissues were obtained for HE staining, Masson staining and transforming growth factor (TGF)-β immunohistochemical staining. Superoxide dismutase (SOD), malondialdehyde (MDA) and glutathione (GSH) were detected in tissue homogenates. The BATMAN-TCM database was used to retrieve the chemical components and their corresponding targets of Qingfei oral solution by network pharmacology method, and then the component-target-disease network diagram was constructed. Finally, the pathway enrichment analysis was carried out to explore the molecular mechanism of Qingfei oral liquid against idiopathic fibrosis. Results: Histopathology results showed that Qingfei oral liquid had a similar relieving effect on pulmonary fibrosis as the positive drug pirfenidone; TGF-β secretion had a significant reduction in lung tissues of Qingfei group; and Qingfei oral liquid had better regulatory effect on SOD, MDA and GSH than pirfenidone. The results of component-target-disease network and pathway enrichment analysis showed that the related molecular pathways were concentrated in inflammation, extracellular matrix and cytokines. Conclusion: Qingfei oral liquid has a good therapeutic effect on idiopathic pulmonary fibrosis in rats via regulation of inflammation, extracellular matrix and cytokines.

Key words: Idiopathic pulmonary fibrosis    Qingfei oral liquid    Network pharmacology    Oxidation-reduction    Transforming growth factor-β    Rats
收稿日期: 2021-07-18 出版日期: 2022-05-17
CLC:  R965  
基金资助: 浙江省医药卫生科技计划(2018ZZ006,2021ZZ001)
通讯作者: 黄萍     E-mail: huangping@hmc.edu.cn
服务  
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章  
张轶雯
盛孔胜
宋飞凤
潘宗富
邹小舟
刘宇佳
黄萍

引用本文:

张轶雯,盛孔胜,宋飞凤,潘宗富,邹小舟,刘宇佳,黄萍. 清肺口服液在特发性肺纤维化中的治疗作用及网络药理学研究[J]. 浙江大学学报(医学版), 2022, 51(1): 53-61.

ZHANG Yiwen,SHENG Kongsheng,SONG Feifeng,PAN Zongfu,ZOU Xiaozhou,LIU Yujia,HUANG Ping. Efficacy of Qingfei oral liquid for idiopathic pulmonary fibrosis in rats and related network pharmacology study. J Zhejiang Univ (Med Sci), 2022, 51(1): 53-61.

链接本文:

https://www.zjujournals.com/med/CN/10.3724/zdxbyxb-2021-0203        https://www.zjujournals.com/med/CN/Y2022/V51/I1/53

图 1  造模第21天各组肺组织形态及纤维化表现(苏木精–伊红染色)A: 正常对照组肺组织结构及纤毛结构正常,肺内细支气管上皮完整,排列整齐,气管和血管周围无明显炎症反应,未见纤维化; B: 模型对照组肺内细支气管上皮增生,管壁增厚,管腔狭窄,伴有炎症细胞浸润,肺泡间隔明显增宽,肺组织均见不同程度的纤维化; C: 吡非尼酮组肺纤维化程度明显缓解,病变程度减轻; D: 清肺口服液组肺纤维化程度与吡非尼酮组相近. 标尺=50 μm.
图 2  造模第21天各组大鼠肺组织中胶原沉积情况(马森染色)A: 正常对照组肺组织中较少蓝色的胶原蛋白沉积; B: 模型对照组肺组织中胶原蛋白沉积增加; C:吡非尼酮组肺组织中胶原蛋白沉积较模型对照组减少; D: 清肺口服液组肺组织中胶原蛋白沉积情况与吡非尼酮组相近. 标尺=10 μm.

 组别

第一周

第二周

第三周

±

+

++及以上

±

+

++及以上

±

+

++及以上

正常对照组

6

0

0

0

6

0

0

0

6

0

0

0

模型对照组

1

1

3

1

0

0

2

4

0

0

1

5

吡非尼酮组

3

1

2

0

0

0

5

1

2

0

3

1

清肺口服液组

1

3

1

1

1

0

0

5

0

0

6

0

P

>0.05

>0.05

<0.01

表 1  各组肺组织胶原蛋白沉积程度分级分布比较
图 3  各组肺组织中转化生长因子-β(TGF-β)表达A:正常对照组肺组织中TGF-β(棕色) 几乎不表达; B: 模型对照组肺组织中TGF-β表达增加; C: 吡非尼酮组肺组织中TGF-β表达较模型对照组减少; D: 清肺口服液组肺组织中TGF-β表达与吡非尼酮组相近. 标尺=50 μm.
图 4  各组肺组织中GSH、SOD和MDA含量比较<0.05,<0.01. GSH:谷胱苷肽;SOD:超氧化物歧化酶;MDA:丙二醛.
图 5  清肺口服液抗特发性肺纤维化的成分–靶点–疾病网络
图 6  清肺口服液抗特发性肺纤维化潜在靶点的蛋白–蛋白相互作用网络
图 7  清肺口服液抗特发性肺纤维化的作用靶点基因功能注释A: GO富集分析结果排序前十位生物学过程的气泡图; B: GO富集分析结果排序前十位细胞组成的气泡图; C: GO富集分析结果排序前十位分子功能的气泡图.GO:基因本体.
1 中华医学会呼吸病学分会. 特发性肺(间质)纤维化诊断和治疗指南(草案)[J]. 中华结核和呼吸杂志, 2002, 25(7): 387-389
Respiratory Society of Chinese Medical Association. Guidelines for diagnosis and treatment of idiopathic pulmonary (interstitial) fibrosis (draft)[J]. Chinese Journal of Tuberculosis and Respiratory Diseases, 2002, 25(7): 387-389. (in Chinese)
2 沈沁雪, 彭 红. 特发性肺纤维化病情的临床评估[J]. 中南大学学报(医学版), 2021, 46(3): 309-315
SHEN Qinxue, PENG Hong. Clinical evaluation on idiopathic pulmonary fibrosis[J]. Journal of Central South University (Medical Science), 2021, 46(3): 309-315. (in Chinese)
3 MARTINEZF J, YOWE, FLAHERTYK R, et al.Effect of antimicrobial therapy on respiratory hospitalization or death in adults with idiopathic pulmonary fibrosis[J]JAMA, 2021, 325( 18): 1841.
doi: 10.1001/jama.2021.4956
4 DUCKWORTHA, GIBBONSM A, ALLENR J, et al.Telomere length and risk of idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease: a mendelian randomisation study[J]Lancet Respiratory Med, 2021, 9( 3): 285-294.
doi: 10.1016/S2213-2600(20)30364-7
5 GHUMMANM, DHAMECHAD, GONSALVESA, et al.Emerging drug delivery strategies for idiopathic pulmonary fibrosis treatment[J]Eur J Pharm Biopharm, 2021, 1-12.
doi: 10.1016/j.ejpb.2021.03.017
6 LANCASTERL H, DE ANDRADEJ A, ZIBRAKJ D, et al.Pirfenidone safety and adverse event management in idiopathic pulmonary fibrosis[J]Eur Respir Rev, 2017, 26( 146): 170057.
doi: 10.1183/16000617.0057-2017
7 WONGKARNJANAA, YANAGIHARAT, KOLBM R. Treatment of idiopathic pulmonary fibrosis with Nintedanib: an update[J]Expert Rev Respiratory Med, 2019, 13( 12): 1139-1146.
doi: 10.1080/17476348.2019.1673733
8 RODRÍGUEZ-PORTALJ A. Efficacy and safety of nintedanib for the treatment of idiopathic pulmonary fibrosis: an update[J]Drugs R D, 2018, 18( 1): 19-25.
doi: 10.1007/s40268-017-0221-9
9 LIS, YANGX, LIW, et al.N-acetylcysteine downregulation of lysyl oxidase activity alleviating bleomycin-induced pulmonary fibrosis in rats[J]Respiration, 2012, 84( 6): 509-517.
doi: 10.1159/000340041
10 王彦君, 王雪林, 李欣泽, 等. 中医药治疗特发性肺纤维化研究[J]. 中国中医基础医学杂志, 2021, 27(6):1033-1035
WANG Yanjun, WANG Xuelin, LI Xinze, et al. Study on the treatment of idiopathic pulmonary fibrosis with traditional Chinese medicine[J].Chinese Journal of Basic Medicine in Traditional Chinese Medicine, 2021, 27(6): 1033-1035. (in Chinese)
11 吕 凌, 袁 佺, 王彩霞. 特发性肺纤维化从脾论治思路探讨[J]. 中国中医基础医学杂志, 2016, 22(7): 937-938
LYU Ling, YUAN Tong, WANG Caixia. Discussion on idiopathic pulmonary fibrosis from spleen treatment[J]. Chinese Journal of Basic Medicine in Traditional Chinese Medicine, 2016, 22(7): 937-938. (in Chinese)
12 郑 钰, 吕晓东, 庞立健, 等. 中医药治疗特发性肺纤维化临床研究方法初探[J]. 辽宁中医药大学学报, 2019, 21(11): 102-105
ZHENG Yu, LYU Xiaodong, PANG Lijian, et al. Preliminary study on clinical research methods of Chinese medicine in the treatment of idiopathic pulmonary fibrosis[J]. Journal of Liaoning University of Traditional Chinese Medicine, 2019, 21(11): 102-105. (in Chinese)
13 周俐斐, 芦柏震, 陈峰阳, 等. 清肺合剂的清除自由基和抗氧化作用[J]. 中草药, 2015(37): 2527-2530
ZHOU Lifei, LU Bozhen, CHEN Fengyang, et al. Free radical scavenging and antioxidant effect of Qingfei Mixture[J]. Chinese Traditional Patent Medicine, 2015(37): 2527-2530. (in Chinese)
14 王跃珍, 崔 巍, 王 准, 等. 中肺合剂对血浆 TGF-β和 IL-6 影响及防治放射性肺炎的临床观察[J].中华中医药学刊, 2012, 30(7): 1541-1544
WANG Yuezhen, CUI Wei, WANG Zhun, et al. Clinical study of Zhongfei decoction influence on changes of TGF-β and IL-6 and the preventive effects of on radiation-induced pneumonia[J]. Chinese Archives of Traditional Chinese Medicine, 2012, 30(7): 1541-1544. (in Chinese)
15 TORLAKOVICE E, NIELSENS, FRANCISG, et al.Standardization of positive controls in diagnostic immunohistochemistry[J]Appl Immunohistochem Mol Morphol, 2015, 23( 1): 1-18.
doi: 10.1097/PAI.0000000000000163
16 MACKINNONA C, GIBBONSM A, FARNWORTHS L, et al.Regulation of transforming growth factor-β1-driven lung fibrosis by galectin-3[J]Am J Respir Crit Care Med, 2012, 185( 5): 537-546.
doi: 10.1164/rccm.201106-0965OC
17 ORNATOWSKIW, LUQ, YEGAMBARAMM, et al.Complex interplay between autophagy and oxidative stress in the development of pulmonary disease[J]Redox Biol, 2020, 101679.
doi: 10.1016/j.redox.2020.101679
18 VEITHC, BOOTSA W, IDRISM, et al.Redox imbalance in idiopathic pulmonary fibrosis: a role for oxidant cross-talk between NADPH oxidase enzymes and mitochondria[J]Antioxid Redox Signal, 2019, 31( 14): 1092-1115.
doi: 10.1089/ars.2019.7742
19 OTOUPALOVA E, SMITH S, CHENG G, et al. Oxidative stress in pulmonary fibrosis[J]. Compr Physiol, 2020, 10(2): 509-547
20 DIAZK T, SKARIAS, HARRISK, et al.Delivery and safety of inhaled interferon-γ in idiopathic pulmonary fibrosis[J]J Aerosol Med Pulmonary Drug Deliver, 2012, 25( 2): 79-87.
doi: 10.1089/jamp.2011.0919
21 LEE J, ARISI I, PUXEDDU E, et al. Bronchoalveolar lavage (BAL) cells in idiopathic pulmonary fibrosis express a complex pro-inflammatory, pro-repair, angiogenic activation pattern, likely associated with macrophage iron accumulation[J/OL]. PLoS One, 2018, 13(4): e0194803
22 BURMANA, KROPSKIJ A, CALVIC L, et al.Localized hypoxia links ER stress to lung fibrosis through induction of C/EBP homologous protein[J/OL]JCI Insight, 2018, 3( 16): e99543.
doi: 10.1172/jci.insight.99543
23 KNOBLOCHJ, LINY, KONRADIJ, et al.Inflammatory responses of airway smooth muscle cells and effects of endothelin receptor antagonism[J]Am J Respir Cell Mol Biol, 2013, 49( 1): 114-127.
doi: 10.1165/rcmb.2012-0287OC
24 ZHUY, TANJ, XIEH, et al.HIF‐1α regulates EMT via the Snail and β‐catenin pathways in paraquat poisoning‐induced early pulmonary fibrosis[J]J Cell Mol Med, 2016, 20( 4): 688-697.
doi: 10.1111/jcmm.12769
25 PHILIPK, MILLST W, DAVIESJ, et al.HIF1A up‐regulates the ADORA2B receptor on alternatively activated macrophages and contributes to pulmonary fibrosis[J]Faseb J, 2017, 31( 11): 4745-4758.
doi: 10.1096/fj.201700219R
26 ZHANGY, LUW, ZHANGX, et al.Cryptotanshinone protects against pulmonary fibrosis through inhibiting Smad and STAT3 signaling pathways[J]Pharmacol Res, 2019, 104307.
doi: 10.1016/j.phrs.2019.104307
27 SHOCHETG E, BROOKE, BARDENSTEIN-WALDB, et al.Integrin alpha-5 silencing leads to myofibroblastic differentiation in IPF-derived human lung fibroblasts[J]Therapeutic Adv Chronic Dis, 2020, 204062232093602.
doi: 10.1177/2040622320936023
[1] 曹秋丽,黎小炜,禤秀萍,黄松,谢雪梅. 宫内发育迟缓出生后追赶生长大鼠脂肪组织LRP6/β-catenin通路表达变化[J]. 浙江大学学报(医学版), 2021, 50(6): 755-761.
[2] 李敏,朱再满,叶政,王惠,刘克宇. 海马CA3区θ~γ神经振荡模拟刺激对大鼠空间认知能力的影响[J]. 浙江大学学报(医学版), 2021, 50(6): 762-769.
[3] 邹玉林,崔秀明,向巧,郭敏,梁应忠,曲媛,杨晓艳. 酱头抗胃溃疡的作用及机制研究[J]. 浙江大学学报(医学版), 2021, 50(5): 561-567.
[4] 苗路伟,赵彤,高迎春,景临林,黄琼,马慧萍. 7-羟乙基白杨素对低压性缺氧大鼠运动性疲劳具有保护作用[J]. 浙江大学学报(医学版), 2021, 50(5): 575-581.
[5] 刘俊霞,赵桂桂,牛岩,甘婷,闫震宇,张雅素. 电针疗法对脑卒中大鼠肢体痉挛的改善作用[J]. 浙江大学学报(医学版), 2021, 50(3): 361-368.
[6] 李扬,李伟光,冯泽国,宋杰,张成岗,黄连军,宋燕平. 手术创伤及多次丙泊酚麻醉对发育期大鼠神经发育和认知功能的影响[J]. 浙江大学学报(医学版), 2021, 50(3): 290-297.
[7] 张玉荣,王瑞忠,王莉,陈蕊. 母婴分离诱导子代抑郁大鼠肠道氨基酸代谢失调[J]. 浙江大学学报(医学版), 2021, 50(3): 298-304.
[8] 张冉,刘云,张翠,马梦尧,李曙,洪云. 盐诱导激酶2对脑缺血再灌注大鼠脑组织能量代谢的影响[J]. 浙江大学学报(医学版), 2021, 50(3): 352-360.
[9] 汪亚楠,闫孝明,张晴宇,宋爱华,韩飞. 基于网络药理学和分子对接技术探讨葛花-枳椇子治疗酒精性肝损伤的潜在作用机制[J]. 浙江大学学报(医学版), 2020, 49(6): 714-724.
[10] 郑心甜,甘海燕,李琳,胡小伟,方燕,储利胜. 黄芪甲苷通过促进小胶质细胞/巨噬细胞M2型极化抑制大鼠脑缺血后炎症反应[J]. 浙江大学学报(医学版), 2020, 49(6): 679-686.
[11] 诸葛陆杰,方燕,金华倩,李琳,杨琰,胡小伟,储利胜. 补阳还五汤上调miR-199a-5p表达促进脑缺血大鼠神经发生和血管生成[J]. 浙江大学学报(医学版), 2020, 49(6): 687-696.
[12] 袁雪纯,向大伟,敏琼,丁怡丹,赵安鹏,王荣. 急进高原缺氧对大鼠肝脏孕烷X受体表达的影响[J]. 浙江大学学报(医学版), 2019, 48(6): 603-608.
[13] 邵佳乐,李志忠,周建,李凯,秦荣,陈克明. 低频脉冲电磁场通过IGF-1R/NO信号通路促进大鼠颅骨成骨细胞成熟及矿化[J]. 浙江大学学报(医学版), 2019, 48(2): 158-164.
[14] 吴超,陈国仙,赵刘阳,李曙,洪云. PeriCam PSI血流灌注成像系统在脑缺血再灌注动物模型中的应用及评价[J]. 浙江大学学报(医学版), 2018, 47(1): 51-56.
[15] 葸慧荣,高玉海,杨芳芳,李文苑,马慧萍,陈克明. 白藜芦醇对生长期大鼠峰值骨量的影响[J]. 浙江大学学报(医学版), 2017, 46(6): 578-584.